Gaeta Renee 4
Research Summary
AI-generated summary
Outset Medical (OM) CFO Renee Gaeta Receives RSU Award
What Happened
Renee Gaeta, Chief Financial Officer of Outset Medical (OM), received a grant of 71,630 restricted stock units (RSUs) on June 26, 2026. The reported acquisition price is $0.00 (typical for compensation awards), so no cash changed hands. This was an award/grant (code A), not a market purchase or sale.
Key Details
- Transaction date: June 26, 2026; Filing date: June 29, 2026 (filed within the SEC Form 4 reporting window).
- Amount: 71,630 RSUs granted; reported price: $0.00; reported total value: $0.
- Shares owned after transaction: Not specified in the provided filing details.
- Footnote (F1): Each RSU converts to one share if vested. Vesting: 33.33% on June 26, 2027; remaining 66.67% vest in equal quarterly installments over the following two years (Feb 15, May 15, Aug 15, Nov 15), subject to continuous service.
- Transaction code: A = Award/Grant. No tax-withholding or sale-to-cover reported in this filing.
Context
RSU grants are a common form of executive compensation and do not indicate an immediate buy or sell signal—shares are only delivered if and when the RSUs vest. Because the grant carries a multi-year vesting schedule tied to continued service, the economic benefit to the insider is realized over time.